| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 28.45▼ | 28.59▼ | 28.77▼ | 29.12▼ | 30.88▼ |
| MA10 | 28.46▼ | 28.75▼ | 28.66▼ | 29.26▼ | 30.64▼ |
| MA20 | 28.53▼ | 28.64▼ | 28.98▼ | 31.23▼ | 30.08▼ |
| MA50 | 28.78▼ | 29.17▼ | 29.36▼ | 30.70▼ | 35.95▼ |
| MA100 | 28.64▼ | 29.33▼ | 30.12▼ | 30.41▼ | 26.65▲ |
| MA200 | 28.92▼ | 30.37▼ | 31.28▼ | 34.93▼ | 22.12▲ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.003▲ | 0.017▲ | -0.019▼ | -0.355▼ | 0.175▲ |
| RSI | 38.815▼ | 42.206▼ | 39.771▼ | 39.181▼ | 44.521▼ |
| STOCH | 39.943 | 41.089 | 52.318 | 24.695 | 50.373 |
| WILL %R | -65.517 | -65.132 | -69.186 | -91.808▼ | -57.914 |
| CCI | -45.516 | -43.001 | -82.529 | -101.923▼ | -38.735 |
|
Tuesday, July 01, 2025 04:38 AM
AbbVie gains control of an in vivo CAR-T therapy that could overcome limitations with currently approved autologous counterparts.
|
|
Monday, June 30, 2025 08:59 AM
Arcturus Therapeutics Holdings Inc. (the "Company", "Arcturus", Nasdaq: ARCT), a commercial messenger RNA medicines company focused on the development of infectious disease vaccines and opportunities ...
|
|
Monday, June 30, 2025 08:09 AM
US pharma major AbbVie is to buy Capstan Therapeutics, a San Diego-based biotech advancing in vivo engineering of cells through RNA delivery using tLNPs, for up to $2.1 billion in cash.
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 01/07/25 | 28.60 | 29.44 | 27.92 | 28.45 | 1,020,499 |
| 30/06/25 | 29.16 | 29.733 | 28.37 | 28.40 | 911,619 |
| 27/06/25 | 29.92 | 30.52 | 28.92 | 29.03 | 1,312,456 |
| 26/06/25 | 30.04 | 30.3787 | 29.06 | 29.83 | 570,636 |
| 25/06/25 | 29.81 | 30.02 | 29.11 | 29.90 | 815,420 |
| 24/06/25 | 30.04 | 30.295 | 29.23 | 29.87 | 1,350,275 |
| 23/06/25 | 29.01 | 29.68 | 28.36 | 29.15 | 990,583 |
| 20/06/25 | 29.41 | 29.65 | 28.38 | 29.31 | 1,469,547 |
| 18/06/25 | 29.44 | 30.02 | 28.88 | 29.32 | 989,200 |
| 17/06/25 | 30.24 | 31.255 | 29.27 | 29.36 | 1,668,099 |
|
|
||||
|
|
||||
|
|